ARS Pharmaceuticals, Inc.
SPRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$45 | -$34 | $50 |
| Dep. & Amort. | $2 | $0 | -$2 | -$2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $5 | $5 | $4 |
| Change in WC | -$1 | -$1 | -$10 | -$11 |
| Other Non-Cash | -$3 | $1 | $0 | $0 |
| Operating Cash Flow | -$47 | -$40 | -$41 | $42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$127 | -$31 | -$34 | -$163 |
| Inv. Sales/Matur. | $89 | $80 | $64 | $67 |
| Other Inv. Act. | -$6 | $0 | $0 | -$5 |
| Investing Cash Flow | -$45 | $49 | $29 | -$102 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $97 | $0 | $0 | $0 |
| Stock Issued | $0 | $3 | $1 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $0 | $0 | $69 |
| Financing Cash Flow | $100 | $3 | $1 | $71 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | $12 | -$11 | $11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52 | $40 | $51 | $40 |
| End Cash | $60 | $52 | $40 | $51 |
| Free Cash Flow | -$47 | -$40 | -$41 | $42 |